Cutaneous lymphomas (CL) include lymphocytic malignancies derived from B cells, T cells, or other cell types such as natural killer cells. Cutaneous T-cell lymphomas are the most common CL, especially mycosis fungoides, Sézary syndrome, and the spectrum of large-cell CD30(+) lymphoproliferative disorders. It is important to understand that these diseases have a much better prognosis than their nodal counterparts; therefore, treatment has to be stage adapted and palliative. Due to the anatomical localization, these lymphomas have significant impact on the quality of life of the patient.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3816/clm.2000.s.004 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!